NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 969000000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2021-06-30)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2022-06-30
Retrieved: 2026-08-24T01:16:43.432851+02:00
Raw response sha256: 4b939697280ac39fb4dbe1da385970e5…
Cite as: FACTANKER, https://factanker.com/fact/91bd7e2c-6a50-45f6-aa77-29517b41227d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies